ARTEMISMED347.00

Artemis Medicare Services Limited

· Pharma & Health
₹ CrorePeersINDRAMEDCOSHALBYGKSLGPTHEALTHLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹5,493 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
2Y
CAGR
Revenue+15.4+10.9
EBITDA+24.0+19.1
Net Income+26.2+45.3
EPS (adj.)+25.4+45.2
Total Assets+5.2+21.3
Total Equity+11.5+43.8
Free Cash Flow-48.5-13.8
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.